Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Dutasteride Capsules in Healthy Japanese Males
NCT02578953Phase 1Completed
- Sponsor
- GSK
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dutasteride in benign prostatic hyperplasia (BPH) (2 arms), sponsored by GSK. Primary endpoints: Area under the plasma concentration-time curve from time zero to the last measurable concentration and Maximal measured plasma concentration. Started Sep 2015; status: completed.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02578953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578953.